BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32758256)

  • 21. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.
    Nishida N; Yada N; Hagiwara S; Sakurai T; Kitano M; Kudo M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1646-53. PubMed ID: 26875698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour?
    Turato C; Buendia MA; Fabre M; Redon MJ; Branchereau S; Quarta S; Ruvoletto M; Perilongo G; Grotzer MA; Gatta A; Pontisso P
    Eur J Cancer; 2012 May; 48(8):1219-26. PubMed ID: 21737255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.
    Sha YL; Liu S; Yan WW; Dong B
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31511432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatoblastomas exhibit marked
    Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
    Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma.
    Huang S; Chen J; Tian R; Wang J; Xie C; Gao H; Shan Y; Hong J; Zhang Z; Xu M; Gu S
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27032. PubMed ID: 29528187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
    Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma.
    Ilmer M; Garnier A; Vykoukal J; Alt E; von Schweinitz D; Kappler R; Berger M
    Mol Cancer Ther; 2015 Dec; 14(12):2712-21. PubMed ID: 26516161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver tumours.
    Perilongo G; Shafford EA
    Eur J Cancer; 1999 Jun; 35(6):953-8; discussion 958-9. PubMed ID: 10533478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter Hypermethylation of Tumor-Suppressor Genes
    Liyanage C; Wathupola A; Muraleetharan S; Perera K; Punyadeera C; Udagama P
    Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation as a key epigenetic player for hepatoblastoma characterization.
    Rivas M; Aguiar T; Fernandes G; Lemes R; Caires-Júnior L; Goulart E; Telles-Silva K; Maschietto M; Cypriano M; de Toledo S; Carraro D; da Cunha I; da Costa C; Rosenberg C; Krepischi A
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101684. PubMed ID: 33852955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.
    Jia D; Dong R; Jing Y; Xu D; Wang Q; Chen L; Li Q; Huang Y; Zhang Y; Zhang Z; Liu L; Zheng S; Xia Q; Wang H; Dong K; He X
    Hepatology; 2014 Nov; 60(5):1686-96. PubMed ID: 24912477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans.
    Zhang S; Zhang J; Evert K; Li X; Liu P; Kiss A; Schaff Z; Ament C; Zhang Y; Serra M; Evert M; Chen N; Xu F; Chen X; Tao J; Calvisi DF; Cigliano A
    Am J Pathol; 2020 Jul; 190(7):1397-1413. PubMed ID: 32283103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas.
    Nagai H; Naka T; Terada Y; Komazaki T; Yabe A; Jin E; Kawanami O; Kishimoto T; Konishi N; Nakamura M; Kobayashi Y; Emi M
    J Hum Genet; 2003; 48(2):65-9. PubMed ID: 12601549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
    Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
    BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma.
    Li X; Kogner P; Sandstedt B; Haas OA; Ekström TJ
    Int J Cancer; 1998 Jan; 75(2):176-80. PubMed ID: 9462704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt/β-Catenin Perspective.
    Bell D; Ranganathan S; Tao J; Monga SP
    Gene Expr; 2017 Feb; 17(2):141-154. PubMed ID: 27938502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatoblastoma--an attempt of histological subtyping on fine-needle aspiration material.
    Barwad A; Gupta N; Gupta K; Rajwanshi A; Marwaha RK; Rao KL; Dey P; Srinivasan R; Nijhawan R
    Diagn Cytopathol; 2013 Feb; 41(2):95-101. PubMed ID: 22362636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.
    Matsumoto S; Yamamichi T; Shinzawa K; Kasahara Y; Nojima S; Kodama T; Obika S; Takehara T; Morii E; Okuyama H; Kikuchi A
    Nat Commun; 2019 Aug; 10(1):3882. PubMed ID: 31462641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.